Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mallory R Taylor

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Pediatric Blood & Cancer|August 29, 2025
Outcomes for Patients Aged 12-18 Months With Metastatic MYCN Non-Amplified Neuroblastoma and Unfavorable Biologic Features ("Mixed Biology Toddlers"): A Report From the International Neuroblastoma Risk Group (INRG) ProjectMallory R Taylor, James R Anderson, Julie R Park, et al.
Frontiers in Immunology|July 22, 2022
Biobehavioral Implications of Covid-19 for Transplantation and Cellular Therapy RecipientsJennifer M Knight, Mallory R Taylor, Kelly E Rentscher, et al.
Journal of Medical Internet Research|March 23, 2026
Mobile Health App Attitudes and Adoption Among Oncology Providers: Cross-Sectional National SurveyNancy Lau, Kavin Srinakarin, Shannon Jh Hong, et al.
Cancer|July 20, 2024
Resilience and distress among adolescents and young adults receiving hematopoietic cell transplantation: The Promoting Resilience in Stress Management randomized trialAbby R Rosenberg, Mallory R Taylor, Kaitlyn M Fladeboe, et al.
Blood Advances|September 29, 2023
Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysisMallory R Taylor, Steve W Cole, Joelle Strom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid TumorsNavin Pinto, Catherine M Albert, Mallory R Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2026
The first-in-human ENCIT01 trial comparing second- versus third-generation L1CAM-specific CAR T cells in patients with primary refractory or relapsed neuroblastomaNavin Pinto, Annette Künkele, Catherine M Albert, et al.
Transplantation and Cellular Therapy|June 22, 2025
Assessing physical function in transplantation and CAR-T recipients: expert recommendations from the survivorship, aging and biobehavioral special interest groups of ASTCTShatha Farhan, Vanessa E Kennedy, Manuel R Espinoza-Gutarra, et al.
Transplantation and Cellular Therapy|July 4, 2025
Assessing cognitive function in transplantation and chimeric antigen receptor t cell therapy recipients: Expert recommendations from the survivorship, aging and biobehavioral special interest groups of the American Society for Transplantation and Cellular TherapyVanessa E Kennedy, Nausheen Ahmed, Andy Artz, et al.
Genetics in Medicine Open|November 1, 2024
Clinical RNA sequencing clarifies variants of uncertain significance identified by prior testingJonathan Marquez, Jennifer N Cech, Cate R Paschal, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Pediatric Blood & Cancer|August 29, 2025
Outcomes for Patients Aged 12-18 Months With Metastatic MYCN Non-Amplified Neuroblastoma and Unfavorable Biologic Features ("Mixed Biology Toddlers"): A Report From the International Neuroblastoma Risk Group (INRG) ProjectMallory R Taylor, James R Anderson, Julie R Park, et al.
Frontiers in Immunology|July 22, 2022
Biobehavioral Implications of Covid-19 for Transplantation and Cellular Therapy RecipientsJennifer M Knight, Mallory R Taylor, Kelly E Rentscher, et al.
Journal of Medical Internet Research|March 23, 2026
Mobile Health App Attitudes and Adoption Among Oncology Providers: Cross-Sectional National SurveyNancy Lau, Kavin Srinakarin, Shannon Jh Hong, et al.
Cancer|July 20, 2024
Resilience and distress among adolescents and young adults receiving hematopoietic cell transplantation: The Promoting Resilience in Stress Management randomized trialAbby R Rosenberg, Mallory R Taylor, Kaitlyn M Fladeboe, et al.
Blood Advances|September 29, 2023
Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysisMallory R Taylor, Steve W Cole, Joelle Strom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid TumorsNavin Pinto, Catherine M Albert, Mallory R Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2026
The first-in-human ENCIT01 trial comparing second- versus third-generation L1CAM-specific CAR T cells in patients with primary refractory or relapsed neuroblastomaNavin Pinto, Annette Künkele, Catherine M Albert, et al.
Transplantation and Cellular Therapy|June 22, 2025
Assessing physical function in transplantation and CAR-T recipients: expert recommendations from the survivorship, aging and biobehavioral special interest groups of ASTCTShatha Farhan, Vanessa E Kennedy, Manuel R Espinoza-Gutarra, et al.
Transplantation and Cellular Therapy|July 4, 2025
Assessing cognitive function in transplantation and chimeric antigen receptor t cell therapy recipients: Expert recommendations from the survivorship, aging and biobehavioral special interest groups of the American Society for Transplantation and Cellular TherapyVanessa E Kennedy, Nausheen Ahmed, Andy Artz, et al.
Genetics in Medicine Open|November 1, 2024
Clinical RNA sequencing clarifies variants of uncertain significance identified by prior testingJonathan Marquez, Jennifer N Cech, Cate R Paschal, et al.
Pageof 3